# RNF34

## Overview
RNF34 is a gene that encodes the ring finger protein 34, an E3 ubiquitin ligase involved in various cellular processes, including protein degradation and immune regulation. The protein is characterized by its ring finger domain, which facilitates the transfer of ubiquitin to target proteins, marking them for proteasomal degradation. This activity is crucial for maintaining cellular homeostasis and regulating metabolic and immune responses. RNF34 plays a significant role in brown fat cell metabolism by targeting the transcriptional coactivator PGC-1α, thereby influencing energy metabolism and thermogenesis (Wei2012RNF34). Additionally, RNF34 is involved in the modulation of inflammasome activity, impacting immune responses and inflammation (Li2023A). The gene's involvement in various signaling pathways underscores its importance in health and disease, with implications in conditions such as myocardial infarction, cancer, and autoimmune diseases (Chen2022The; Xu2021TAX1BP1).

## Function
RNF34 (ring finger protein 34) is an E3 ubiquitin ligase that plays a crucial role in protein degradation through the ubiquitin-proteasome system. It is involved in the regulation of brown fat cell metabolism by targeting PGC-1α, a transcriptional coactivator, for ubiquitination and subsequent proteasomal degradation. This process is essential for controlling energy metabolism and adaptive thermogenesis in brown fat cells. RNF34 specifically interacts with the C-terminal half of PGC-1α, promoting its turnover and reducing its nuclear presence, which affects the expression of PGC-1α target genes and oxygen consumption in brown fat cells (Wei2012RNF34).

In endothelial cells, RNF34 is part of the ZFYVE21-Rubicon-RNF34 signaling complex on Rab5 endosomes, where it modulates inflammasome activity. It facilitates the ubiquitination and removal of the caspase-1 pseudosubstrate, Flightless I (FliI), enhancing the availability of caspase-1 for activation. This activity is crucial for the assembly of inflammasomes, which are involved in the maturation of IL-1 family cytokines and play a role in tissue inflammation (Li2023A). RNF34's function in these processes highlights its importance in maintaining cellular homeostasis and regulating immune responses.

## Clinical Significance
Alterations in the expression or function of the RNF34 gene have been implicated in various diseases. In the context of complement-mediated diseases, RNF34 is part of the ZFYVE21-Rubicon-RNF34 (ZRR) signaling complex, which is upregulated in conditions such as antibody-mediated rejection (ABMR), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE) nephritis. This complex is associated with endothelial cell activation and inflammation, suggesting a role in these diseases (Li2023A).

In myocardial infarction, RNF34 is involved in the TAX1BP1-mediated pathway that protects against cardiac anomalies by inhibiting inflammasomes. The gene facilitates the autophagic degradation of MAVS, which is crucial for preventing NLRP3 inflammasome activation and subsequent cardiac damage under hypoxic conditions (Xu2021TAX1BP1).

RNF34 also plays a role in cancer progression by regulating apoptosis and cell proliferation. It induces the degradation of death effector domain caspases and p53, thereby suppressing apoptosis and promoting cancer cell growth (Chen2022The). In colorectal cancer, RNF34 is noted for its involvement in pathways related to cancer progression (Huo2017Colorectal).

These findings highlight the clinical significance of RNF34 in inflammatory, cardiac, and cancer-related conditions.

## Interactions
RNF34, a ring finger protein, is an E3 ubiquitin ligase that participates in various protein interactions, influencing multiple cellular processes. It interacts with PGC-1α, a transcriptional coactivator involved in energy metabolism and mitochondrial biogenesis. RNF34 promotes the ubiquitination and proteasomal degradation of PGC-1α, thereby regulating its protein levels and activity in brown fat cells and brain tissues (Qu2019RNF34; Wei2012RNF34).

RNF34 is also involved in the regulation of inflammasome activity through its interaction with proteins such as Rubicon and ZFYVE21. These proteins form a complex with RNF34 on Rab5 endosomes, enhancing inflammasome activity by modulating the stability and interactions of immune-related proteins like caspase-1 and Flightless I (FliI) (Li2023A). RNF34 ubiquitinylates FliI, facilitating its removal from endosomes and increasing caspase-1 availability (Li2023A).

In the context of cystic fibrosis, RNF34 interacts with the cystic fibrosis transmembrane conductance regulator (CFTR), particularly the ΔF508-CFTR variant. It colocalizes with RFFL in endosomal compartments, contributing to the ubiquitination and degradation of misfolded CFTR proteins (Taniguchi2022The). These interactions highlight RNF34's role in protein quality control and cellular stress responses.


## References


[1. (Qu2019RNF34) Xin Qu, Ning Wang, Wenjin Chen, Meng Qi, Yueqiao Xue, and Weitao Cheng. Rnf34 overexpression exacerbates neurological deficits and brain injury in a mouse model of intracerebral hemorrhage by potentiating mitochondrial dysfunction-mediated oxidative stress. Scientific Reports, November 2019. URL: http://dx.doi.org/10.1038/s41598-019-52494-x, doi:10.1038/s41598-019-52494-x. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-019-52494-x)

[2. (Xu2021TAX1BP1) Haixia Xu, Wenjun Yu, Shiqun Sun, Congye Li, Jun Ren, and Yingmei Zhang. Tax1bp1 protects against myocardial infarction-associated cardiac anomalies through inhibition of inflammasomes in a rnf34/mavs/nlrp3-dependent manner. Science Bulletin, 66(16):1669–1683, August 2021. URL: http://dx.doi.org/10.1016/j.scib.2021.01.030, doi:10.1016/j.scib.2021.01.030. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.scib.2021.01.030)

[3. (Taniguchi2022The) Shogo Taniguchi, Yukiko Ito, Hibiki Kiritani, Asuka Maruo, Ryohei Sakai, Yuji Ono, Ryosuke Fukuda, and Tsukasa Okiyoneda. The ubiquitin ligase rnf34 participates in the peripheral quality control of cftr (rnf34 role in cftr periqc). Frontiers in Molecular Biosciences, March 2022. URL: http://dx.doi.org/10.3389/fmolb.2022.840649, doi:10.3389/fmolb.2022.840649. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmolb.2022.840649)

[4. (Wei2012RNF34) Ping Wei, Dongning Pan, Chunxiao Mao, and Yong-Xu Wang. Rnf34 is a cold-regulated e3 ubiquitin ligase for pgc-1α and modulates brown fat cell metabolism. Molecular and Cellular Biology, 32(2):266–275, January 2012. URL: http://dx.doi.org/10.1128/MCB.05674-11, doi:10.1128/mcb.05674-11. This article has 48 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.05674-11)

[5. (Huo2017Colorectal) Tianyao Huo, Ronald Canepa, Andrei Sura, François Modave, and Yan Gong. Colorectal cancer stages transcriptome analysis. PLOS ONE, 12(11):e0188697, November 2017. URL: http://dx.doi.org/10.1371/journal.pone.0188697, doi:10.1371/journal.pone.0188697. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0188697)

[6. (Chen2022The) Xuankun Chen, Li Jiang, Zhesheng Zhou, Bo Yang, Qiaojun He, Chengliang Zhu, and Ji Cao. The role of membrane-associated e3 ubiquitin ligases in cancer. Frontiers in Pharmacology, July 2022. URL: http://dx.doi.org/10.3389/fphar.2022.928794, doi:10.3389/fphar.2022.928794. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2022.928794)

[7. (Li2023A) Xue Li, Quan Jiang, Guiyu Song, Mahsa Nouri Barkestani, Qianxun Wang, Shaoxun Wang, Matthew Fan, Caodi Fang, Bo Jiang, Justin Johnson, Arnar Geirsson, George Tellides, Jordan S. Pober, and Dan Jane-wit. A zfyve21-rubicon-rnf34 signaling complex promotes endosome-associated inflammasome activity in endothelial cells. Nature Communications, May 2023. URL: http://dx.doi.org/10.1038/s41467-023-38684-2, doi:10.1038/s41467-023-38684-2. This article has 3 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-023-38684-2)